PITTSBURGH (AP) _ NeuBase Therapeutics, Inc. (NBSE) on Thursday reported a loss of $5.5 million in its fiscal second quarter.
On a per-share basis, the Pittsburgh-based company said it had a loss of 24 cents.
In the final minutes of trading on Thursday, the company's shares hit $4.64. A year ago, they were trading at $8.69.
The Associated Press